NexgenRx, Inc. (NXG.V)

0.34 +0.02 (+4.62%) CAD  |  TSXV  |  Mar 03, 16:00
More

NexgenRx EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NXG.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Cronos Group, Inc. Upgrade
Cannara Biotech, Inc. (DELISTED) Upgrade
Medexus Pharmaceuticals, Inc. Upgrade
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. Upgrade